TY - JOUR
T1 - Loss of FMR2 further emphasizes the link between deregulation of immediate early response genes FOS and JUN and intellectual disability
AU - Melko, Mireille
AU - Nguyen, Lam S.
AU - Shaw, Marie
AU - Jolly, Lachlan
AU - Bardoni, Barbara
AU - Gecz, Jozef
N1 - Funding Information:
This work was supported by the Australian NH&MRC Program Grant 628952 to J.G., by INSERM, CNRS, Agence Nationale de la Recherche: ANR-Rare-09-02 and ANR-11-LABX-0028-01, Fondation pour la Recherche Médicale and Fondation Jérôme Lejeune to B.B. M.M. was recipient of an ‘EMBO Short Term Fellowship’ and a fellowship ‘La Ligue contre le Cancer’. L.S.N.’s PhD scholarship was supported by the MS McLeod Foundation. J.G. is supported by the Australian NH&MRC Principal Research Fellowship APP1041920. The authors are grateful to FAST (France Australia Science and Technology) program.
PY - 2013/8
Y1 - 2013/8
N2 - Loss of FMR2 causes Fragile X E (FRAXE) site-associated intellectual disability (ID). FMR2 regulates transcription, promotes alternative splicing with preference for G-quartet structure harbouring exons and is localized to the nuclear speckles. In primary skin fibroblasts from FRAXE patients (n=8), we found a significant reduction in the number, but a significant increase in the size, of nuclear speckles, when compared with the controls (n= 4). Since nuclear speckles are enriched with factors involved in pre-mRNA processing, we explored the consequence of these defects and the loss of FMR2 on the transcriptome. We performed whole genome expression profiling using total RNA extracted from these cell lines and found 27 genes significantly deregulated by at least 2-fold at P < 0.05 in the patients. Among these genes, FOS was significantly upregulated and was further investigated due to its established role in neuronal cell function. We showed that (i) 30% depletion of Fmr2 in mouse primary cortical neurons led to a 2-fold increase in Fos expression, (ii) overexpression of FMR2 significantly decreased FOS promoter activity in luciferase assays, and (iii) as FOS promoter contains a serum response element, we found that not FOS, but JUN, which encodes for a protein that forms a transcriptional activator complex with FOS, was significantly upregulated in the patients' cell lines upon mitogen stimulation. These results suggest that FMR2 is an upstream regulator of FOS and JUN, and further link deregulation of the immediate early response genes to the pathology of ID- and FRAXE-associated ID in particular.
AB - Loss of FMR2 causes Fragile X E (FRAXE) site-associated intellectual disability (ID). FMR2 regulates transcription, promotes alternative splicing with preference for G-quartet structure harbouring exons and is localized to the nuclear speckles. In primary skin fibroblasts from FRAXE patients (n=8), we found a significant reduction in the number, but a significant increase in the size, of nuclear speckles, when compared with the controls (n= 4). Since nuclear speckles are enriched with factors involved in pre-mRNA processing, we explored the consequence of these defects and the loss of FMR2 on the transcriptome. We performed whole genome expression profiling using total RNA extracted from these cell lines and found 27 genes significantly deregulated by at least 2-fold at P < 0.05 in the patients. Among these genes, FOS was significantly upregulated and was further investigated due to its established role in neuronal cell function. We showed that (i) 30% depletion of Fmr2 in mouse primary cortical neurons led to a 2-fold increase in Fos expression, (ii) overexpression of FMR2 significantly decreased FOS promoter activity in luciferase assays, and (iii) as FOS promoter contains a serum response element, we found that not FOS, but JUN, which encodes for a protein that forms a transcriptional activator complex with FOS, was significantly upregulated in the patients' cell lines upon mitogen stimulation. These results suggest that FMR2 is an upstream regulator of FOS and JUN, and further link deregulation of the immediate early response genes to the pathology of ID- and FRAXE-associated ID in particular.
UR - http://www.scopus.com/inward/record.url?scp=84880252811&partnerID=8YFLogxK
U2 - 10.1093/hmg/ddt155
DO - 10.1093/hmg/ddt155
M3 - Article
C2 - 23562910
AN - SCOPUS:84880252811
SN - 0964-6906
VL - 22
SP - 2984
EP - 2991
JO - Human molecular genetics
JF - Human molecular genetics
IS - 15
ER -